Ask the experts – COVID-19 and NMD
Many people with neuromuscular disease have questions about COVID-19. Muscular Dystrophy Canada (MDC) invites you to send your questions to , where they will be answered by neuromuscular specialists, respirologists, and researchers from across Canada.
You can find the current compilation of questions and answers on this regularly updated FAQ page.
Please note that these recommendations should supplement, but not replace the recommendations made by your doctor or your local public health authority. Please speak to your healthcare provider if you have any further questions.
Read next...
Lower Extremity Muscle Strengthening Program in Myotonic Dystrophy Type 1 from Groupe de recherche interdisciplinaire sur les maladies neuromusculaires
The Groupe de recherche interdisciplinaire sur les maladies neuromusculaires (GRIMN) recently created a video aimed at health professionals that provides an in-depth explanation of the Myotonic dystrophy (DM1) training parameters used in their studies.
Fifth Annual Clinical Fellowship Competition from NMD4C and MDC Opens May 1st
The NMD4C and MDC clinical neuromuscular fellowship competition is accepting applications for the 2026 competition until June 12, 2025.
King’s Medal Awarded to Canadian Neuromuscular Clinicans and Researchers
Several NMD4C investigators and collaborators from the Canadian neuromuscular community have been awarded a King Charles III’s Coronation Medal in recognition of their outstanding contributions and service.
New Home on NMD4C Website for Community of Practice
Check out the new home for the NMD4C community of practice (CoP), now live on the NMD4C website!
